Kerstin Schaefer‐Eckart

Therapeutic platelet transfusion versus routine prophylactic transfusion in patients with haematological malignancies: an open-label, multicentre, randomised study

Hannes Wandt, Kerstin Schaefer‐Eckart, Knut Wendelin et al. · The Lancet · 2012 · 335 citations

Thrombosis, Blood Platelet, Therapeutic Platelet Transfusion +10

Treosulfan or busulfan plus fludarabine as conditioning treatment before allogeneic haemopoietic stem cell transplantation for older patients with acute myeloid leukaemia or myelodysplastic syndrome (MC-FludT.14/L): a randomised, non-inferiority, phase 3 trial

Dietrich W. Beelen, Rudolf Trenschel, Matthias Stelljes et al. · The Lancet Haematology · 2019 · 147 citations · Full text

Reduced intensity conditioning for allogeneic hematopoietic stem cell transplantation in patients with acute myeloid leukemia: disease status by marrow blasts is the strongest prognostic factor

Herbert G. Sayer, M. Kröger, J. Beyer et al. · Bone Marrow Transplantation · 2003 · 145 citations

Hematological Malignancy, Transplantation, Marrow Transplantation +11

Successful adoptive transfer and in vivo expansion of haploidentical γδ T cells

Martin Wilhelm, Manfred Smetak, Kerstin Schaefer‐Eckart et al. · Journal of Translational Medicine · 2014 · 138 citations · Full text

A prospective randomized controlled trial comparing PCR-based and empirical treatment with liposomal amphotericin B in patients after allo-SCT

Holger Hebart, Lena Klingspor, Thomas Klingebiel et al. · Bone Marrow Transplantation · 2008 · 116 citations

Medicine, Empirical Treatment, Pharmacology +5